Your browser doesn't support javascript.
loading
Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients.
Fayek, Sameh Adel; Mantipisitkul, Wana; Rasetto, Flavia; Munivenkatappa, Raghava; Barth, Rolf N; Philosophe, Benjamin.
Affiliation
  • Fayek SA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA. sfayek@smail.umaryland.edu
HPB (Oxford) ; 12(10): 657-63, 2010 Dec.
Article in En | MEDLINE | ID: mdl-21083790
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Liver Transplantation / Cytomegalovirus Infections Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: HPB (Oxford) Journal subject: GASTROENTEROLOGIA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Liver Transplantation / Cytomegalovirus Infections Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: HPB (Oxford) Journal subject: GASTROENTEROLOGIA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom